Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$1.14B |
| 2 |
UnitedHealth
UNH
|
+$391M |
| 3 |
Meta Platforms (Facebook)
META
|
+$310M |
| 4 |
Wabtec
WAB
|
+$296M |
| 5 |
Elanco Animal Health
ELAN
|
+$201M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$518M |
| 2 |
Coca-Cola
KO
|
+$358M |
| 3 |
ATHN
Athenahealth, Inc.
ATHN
|
+$323M |
| 4 |
ULTI
Ultimate Software Group Inc
ULTI
|
+$303M |
| 5 |
Starbucks
SBUX
|
+$288M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.08% |
| 2 | Healthcare | 17.92% |
| 3 | Financials | 12.25% |
| 4 | Industrials | 11.03% |
| 5 | Consumer Discretionary | 10.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Evercore
EVR
$13.2B
| $271K | ﹤0.01% |
+2,979
| New | +$262K |
|
1302
Vanguard Consumer Staples ETF
VDC
$7.98B
| $269K | ﹤0.01% |
1,851
-750
| -29% | -$104K |
|
1303
Bio-Rad Laboratories Class A
BIO
$8.47B
| $265K | ﹤0.01% |
866
-483
| -36% | -$130K |
|
1304
MGP Ingredients
MGPI
$384M
| $263K | ﹤0.01% |
+3,414
| New | +$249K |
|
1305
Cullen/Frost Bankers
CFR
$10.3B
| $257K | ﹤0.01% |
2,648
-3,446
| -57% | -$342K |
|
|
AMWD
1306
DELISTED
American Woodmark
AMWD
| $253K | ﹤0.01% |
+3,056
| New | +$228K |
|
1307
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.47B
| $253K | ﹤0.01% |
4,276
-22,113
| -84% | -$1.29M |
|
1308
Brookdale Senior Living
BKD
$3.69B
| $249K | ﹤0.01% |
37,795
+10,127
| +37% | +$74.3K |
|
1309
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.26B
| $249K | ﹤0.01% |
3,459
-19,605
| -85% | -$1.37M |
|
1310
iShare MSCI Eurozone ETF
EZU
$9.45B
| $249K | ﹤0.01% |
+6,459
| New | +$243K |
|
1311
Sunstone Hotel Investors
SHO
$2.2B
| $249K | ﹤0.01% |
17,295
-881,499
| -98% | -$12.7M |
|
1312
Barclays
BCS
$96.3B
| $241K | ﹤0.01% |
30,718
-749
| -2% | -$6.02K |
|
|
JBTM
1313
JBT Marel
JBTM
$7.37B
| $241K | ﹤0.01% |
+2,622
| New | +$221K |
|
|
CSII
1314
DELISTED
Cardiovascular Systems, Inc.
CSII
| $232K | ﹤0.01% |
+5,994
| New | +$203K |
|
|
HA
1315
DELISTED
Hawaiian Holdings, Inc.
HA
| $230K | ﹤0.01% |
8,775
+509
| +6% | +$14.8K |
|
|
BLD
1316
DELISTED
TopBuild
BLD
| $225K | ﹤0.01% |
+3,468
| New | +$195K |
|
1317
Transocean
RIG
$5.84B
| $225K | ﹤0.01% |
25,879
-18,102
| -41% | -$155K |
|
|
BSTC
1318
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $225K | ﹤0.01% |
3,610
-415
| -10% | -$27.5K |
|
1319
Wingstop
WING
$3.74B
| $224K | ﹤0.01% |
+2,943
| New | +$201K |
|
|
QTNA
1320
DELISTED
Quantenna Communications, Inc. Common Stock
QTNA
| $222K | ﹤0.01% |
+9,126
| New | +$159K |
|
|
BMCH
1321
DELISTED
BMC Stock Holdings, Inc
BMCH
| $215K | ﹤0.01% |
12,178
+906
| +8% | +$15.7K |
|
|
STKL
1322
DELISTED
SunOpta
STKL
| $213K | ﹤0.01% |
61,488
-12,036
| -16% | -$46.6K |
|
1323
Alamo Group
ALG
$2B
| $212K | ﹤0.01% |
+2,126
| New | +$192K |
|
1324
Lithia Motors
LAD
$7.88B
| $208K | ﹤0.01% |
+2,242
| New | +$195K |
|
1325
Regal Rexnord
RRX
$14B
| $208K | ﹤0.01% |
2,538
-832
| -25% | -$65.6K |
|
Similar funds
Janus Henderson Group's Q1 2019 Portfolio in Review
As of Q1 2019, Janus Henderson Group held 1,435 positions worth $180B, up 15% from $157B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Janus Henderson Group's Q1 2019 filing shows 105 new, 637 increased, 574 reduced and 94 closed positions. Its largest new stake was Magellan Midstream Partners, L.P.: 1,610,557 shares worth $97.6M. The largest sale was Celgene Corp, an estimated $518M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
- Janus Henderson Group's largest Q1 2019 buy was Magellan Midstream Partners, L.P.: 1,610,557 shares worth $97.6M.
- Janus Henderson Group added most to Walt Disney in Q1 2019, an estimated $1.14B increase.
- Janus Henderson Group's biggest Q1 2019 reduction was Celgene Corp, cutting an estimated $518M.
- Janus Henderson Group fully exited Athenahealth, Inc. in Q1 2019, selling an estimated $323M.
- Janus Henderson Group's ten largest holdings make up 17% of its $180B portfolio in Q1 2019.
- Janus Henderson Group opened 105 new positions and closed 94 in Q1 2019.
- Janus Henderson Group's portfolio value rose 15% quarter-over-quarter to $180B.
Based on Janus Henderson Group's 13F filing for Q1 2019, filed 30 Apr 2019.